Insider trading

Period: 120 months Stock: NPCE Minimum amount: $100K × + Add filter Clear all
Views & alerts

Save your view. Keep the filter you have built, and get an email when a new filing matches it. A free account does both.

When

Period

How far back the list reaches. Filings arrive days after the trade, so the newest rows always lag a little.

22 decisions over 120 months
Who

Role

The position the person holds at the company, read from the title on the filing. A chief executive who is also a director counts as the chief executive.

22 decisions over 120 months
The trade

Type of trade

Purchases, sales, or cluster buys: companies where 3 or more insiders bought within 30 days. The number beside each is what that choice would give.

22 decisions over 120 months
The trade

Minimum amount

Hides rows under this value. The amount is the shares traded times the price on the filing.

22 decisions over 120 months Remove this filter
The trade

Plan

  • Discretionary: they chose to sell that week.
  • Scheduled: a 10b5-1 plan fixed the sale months in advance, so the timing says nothing about what they knew.
  • Not stated: filed before the SEC added the box in April 2023, which is most of the older half of this database.
22 decisions over 120 months
The trade

Share of their own holding

How much of what they already held the trade moved. Selling a tenth of a stake is not the same act as selling all of it.

At least
22 decisions over 120 months
Ownership

What the chief executive holds

The value of the chief executive’s stock measured against base salary. The salary comes from the company’s own proxy. Companies with no figure are in neither direction.

22 decisions over 120 months
Stock
Insider
Type ?
Why it stands out
15 Dec 2025
Morrell Martha CHIEF MEDICAL OFFICER
Sold at will
$399.25K 25,000 at 15.97
33.3%
Not planned
14 May 2025
ORBIMED ADVISORS LLC 10% owner · indirect
Sold at will 2×
$2.67M 168,136 at 15.85
4.9%
Not planned
21 Feb 2025
Morrell Martha CHIEF MEDICAL OFFICER
Sold at will
$1.07M 78,334 at 13.72
48.9%
Not planned
20 Feb 2025
KCK LTD. 10% owner
Sold at will
$49.55M 5,270,845 at 9.40
100%
Sold half or more
25 Oct 2024
KCK LTD. 10% owner
Sold at will
$1.22M 223,991 at 5.45
4.1%
Not planned
2 May 2024
ORBIMED ADVISORS LLC 10% owner · indirect
Sold at will
$123.88K 8,842 at 14.01
0.3%
Not planned
1 May 2024
ORBIMED ADVISORS LLC 10% owner · indirect
Sold at will
$219.97K 15,690 at 14.02
0.5%
Not planned
23 Apr 2024
ORBIMED ADVISORS LLC 10% owner · indirect
Sold at will
$311.39K 21,791 at 14.29
0.6%
Not planned
22 Apr 2024
ORBIMED ADVISORS LLC 10% owner · indirect
Sold at will
$345.76K 24,609 at 14.05
0.7%
Not planned
19 Apr 2024
ORBIMED ADVISORS LLC 10% owner · indirect
Sold at will
$255.91K 18,253 at 14.02
0.5%
Not planned
16 Apr 2024
ORBIMED ADVISORS LLC 10% owner · indirect
Sold at will
$197.11K 14,069 at 14.01
0.4%
Not planned
12 Apr 2024
ORBIMED ADVISORS LLC 10% owner · indirect
Sold at will
$333.12K 23,101 at 14.42
0.7%
Not planned
11 Apr 2024
ORBIMED ADVISORS LLC 10% owner · indirect
Sold at will
$6.69M 461,899 at 14.49
11.5%
Not planned
2 Feb 2024
Morrell Martha Chief Medical Officer
Sold at will
$213.12K 14,143 at 15.07
14.8%
Not planned
30 Jan 2024
Morrell Martha Chief Medical Officer
Sold at will
$170.00K 11,262 at 15.10
10.3%
Not planned
27 Dec 2023
Morrell Martha Chief Medical Officer
Sold at will
$134.65K 13,300 at 10.12
10.8%
Not planned
21 Nov 2022
Bought
$491.51K 327,893 at 1.50
8.1%
21 Apr 2021
Norton Evan Director · indirect
Bought
$10.00M 588,235 at 17.00
opened
First buy on file
21 Apr 2021
Bought
$10.00M 588,235 at 17.00
opened
First buy on file
21 Apr 2021
ORBIMED ADVISORS LLC 10% owner · indirect
Bought
$4.00M 235,000 at 17.00
opened
First buy on file
21 Apr 2021
Fischer Frank M Director
Bought
$850.00K 50,000 at 17.00
115%
First buy on file
21 Apr 2021
Bought
$225.00K 13,235 at 17.00
51.7%
First buy on file
Showing 1–22 of 22.